|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
The SOX11 negative leukemic non-nodal mantle cell lymphomas were also negative by RNAscope.
|
31296581 |
2020 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma.
|
31646825 |
2020 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
A high Mantle Cell Lymphoma International Prognostic Index (MIPI) predicted poorer prognosis in patients with SOX11-negative MCL (P<0.0001), but not SOX11-positive MCL (P=0.09).
|
30768440 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
|
30530749 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
SOX11 is a transcription factor that plays an important role in mantle cell lymphoma development.
|
30922366 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis.
|
31714947 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
|
31173643 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
SOX11, a key oncogenic factor in mantle cell lymphoma.
|
29738333 |
2018 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
|
29158064 |
2018 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
|
29771407 |
2018 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Conclusively, our data suggest that SOX11 represents a useful prognostic marker in mantle cell lymphoma.
|
28429312 |
2017 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
|
28533307 |
2017 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
|
27720733 |
2017 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
|
28466437 |
2017 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
|
26757780 |
2016 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
|
27430213 |
2016 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.
|
24681958 |
2015 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
|
25120048 |
2015 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
|
24145648 |
2014 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
|
24878000 |
2014 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
|
23466598 |
2013 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
|
23321250 |
2013 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
Biomarker
|
disease |
BEFREE |
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
|
22827557 |
2012 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
SOX11 expression in mantle cell lymphoma.
|
20919851 |
2010 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study we found variable expression of SOX11, SOX4 and SOX12 mRNA in mantle cell lymphoma cell lines.
|
21124928 |
2010 |